Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    "Carcinoma, Pancreatic Ductal"
Show Display Options
Rank Status Study
1 Recruiting Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
Condition: Carcinoma, Pancreatic Ductal
Interventions: Procedure: Extended lymphadenectomy;   Procedure: Standard lymphadenectomy
2 Recruiting Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
Condition: Carcinoma, Pancreatic Ductal
Intervention: Genetic: Molecular Profiling
3 Recruiting Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Interventions: Other: iAPA-DC/CTL adoptive cellular immunotherapy;   Drug: Gemcitabine
4 Completed Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: Atu027 & gemcitabine in lead in safety period;   Drug: Atu027 & gemcitabine in treatment arm 1;   Drug: Atu027 & gemcitabine in treatment arm 2
5 Unknown  Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: Paclitaxel and gemcitabine;   Procedure: Hyperfractionated external beam irradiation
6 Recruiting Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas
Condition: Carcinoma, Pancreatic Ductal
Intervention: Other: samples of blood, saliva and urine
7 Recruiting Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Intervention: Drug: Parvovirus H-1 (H-1PV)
8 Completed Circulating Tumor Cells in Operative Blood
Condition: Carcinoma, Pancreatic Ductal
Interventions: Procedure: Peripheral/Central Venous Blood Draw;   Procedure: Peritoneal Wash
9 Unknown  Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: Targeted Therapy Tailored Treatment;   Drug: Standard Chemotherapy
10 Completed
Has Results
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: AG-013736;   Drug: Gemcitabine;   Drug: placebo
11 Recruiting According CTC to Compare the Influences of Different Methods to Remove the PDAC
Conditions: Carcinoma, Pancreatic Ductal;   Circulating Tumor Cells
Interventions: Procedure: routine surgery;   Procedure: no-touch surgery;   Procedure: laparoscopic surgery
12 Recruiting Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Conditions: Resectable Pancreatic Cancer;   Pancreatic Ductal Carcinoma
Interventions: Drug: FOLFIRINOX;   Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Drug: Capecitabine
13 Completed A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Conditions: Carcinoma, Pancreatic Ductal;   Pancreatic Cancer;   Pancreatic Disease
Interventions: Biological: AGS-1C4D4;   Biological: gemcitabine
14 Completed A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Conditions: Carcinoma, Pancreatic Ductal;   Pancreatic Cancer;   Pancreatic Disease
Interventions: Biological: AGS-1C4D4;   Biological: Gemcitabine
15 Active, not recruiting Continuous Monitoring on the General Ward
Conditions: Carcinoma, Pancreatic Ductal;   Colorectal Neoplasms;   Arthritis;   Hypertension;   Sepsis
Interventions: Device: HealthPatch;   Device: ViSi Mobile
16 Recruiting An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
Conditions: Biliary Tract Diseases;   Stomach Neoplasms;   Carcinoma, Pancreatic Ductal;   Barrett Esophagus
Intervention: Device: ExSpiron Respiratory Variation Monitor
17 Terminated Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal;   Mesothelioma;   Ovarian Neoplasms;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Amatuximab (MORab-009)
18 Recruiting Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
Conditions: Diabetes Mellitus, Adult-Onset;   Diabetes Complications;   Carcinoma, Pancreatic Ductal;   Pancreatic Neoplasm
Intervention:
19 Recruiting Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MEDI4736 in combination with nab-paclitaxel and gemcitabine;   Drug: MEDI4736 in combination with AZD5069
20 Active, not recruiting Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MEDI4736 monotherapy;   Drug: tremelimumab+MEDI4736

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.